MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Sodium butyrate attenuates rotenone-induced neurodegeneration via enhancing autophagy and preventing α-synuclein aggregation

L. Liu, C. Han, K. Ma, X. Xu, J. Huang, N. Xiong, T. Wang (Wuhan, People's Republic of China)

Meeting: 2016 International Congress

Abstract Number: 849

Keywords: Dopaminergic neurons, Neuroprotective agents, Parkinsonism, Rotenone

Session Information

Date: Tuesday, June 21, 2016

Session Title: Parkinson's disease: Pathophysiology

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To investigate whether sodium butyrate (NaB) could enhance autophagy and thus exert a neuroprotective effect through the modulation of α-synuclein in animal models of Parkinson’s disease (PD) induced by chronic rotenone administration.

Background: Accumulating evidence suggests a pivotal role for autophagy in the pathogenesis of PD, and dysfunction in the autophagic system could result in a-synuclein aggregation. A number of histone deacetylase (HDAC) inhibitors including NaB have recently become promising therapeutic candidates in many neurological diseases, such as stroke and Huntington’s disease.

Methods: Male C57BL/6 mice aged 12 months were divided into 3 groups: control group, rotenone-only treated group (30 mg/kg/d, p.o.) and group treated with both NaB (0.3 g/kg/d, i.p.) and rotenone (30 mg/kg/d, p.o., 5 times per week for 8 weeks). Histopathological and immunofluorescence analyses, western blots, and TEM were compared among the 3 groups of mice.

Results: NaB administration significantly rescued loss of tyrosine hydroxylase-positive neurons in the substantia nigra in rotenone-treated animals. Importantly, NaB reduced rotenone-induced a-synuclein aggregation in mice, which is widely thought to play a central role in the pathogenesis of PD. Furthermore, compared with animals treated with rotenone only, NaB administration significantly reduced P62 accumulation, increased the number of LC3-II-positive autophagosomes and promoted final maturation of late autophagic vacuoles through fusion with lysosomes. Moreover, NaB protects against rotenone-induced neurotoxicity in mice by regulating autophagy-related signaling pathways including restoring Beclin-1 expression and reducing mTOR expression.

Conclusions: Our findings suggest that NaB exerts neuroprotective effects by enhancing autophagolysosome formation and preventing α-synuclein aggregation in rotenone-treated Parkinsonian models, providing further evidence that HDAC inhibitors may be a promising approach for disease-modifying treatment of PD.

To cite this abstract in AMA style:

L. Liu, C. Han, K. Ma, X. Xu, J. Huang, N. Xiong, T. Wang. Sodium butyrate attenuates rotenone-induced neurodegeneration via enhancing autophagy and preventing α-synuclein aggregation [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/sodium-butyrate-attenuates-rotenone-induced-neurodegeneration-via-enhancing-autophagy-and-preventing-synuclein-aggregation/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/sodium-butyrate-attenuates-rotenone-induced-neurodegeneration-via-enhancing-autophagy-and-preventing-synuclein-aggregation/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley